OTCMKTS:BNXTF BioNxt Solutions Q1 2025 Earnings Report $0.27 0.00 (0.00%) As of 10/2/2026 ProfileEarnings History BioNxt Solutions EPS ResultsActual EPS-$0.01Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ABioNxt Solutions Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ABioNxt Solutions Announcement DetailsQuarterQ1 2025Date6/26/2025TimeAfter Market ClosesConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile BioNxt Solutions Earnings HeadlinesBioNxt Extends Convertible Debentures and Issues 16.9 Million WarrantsAugust 21, 2026 | tipranks.comBioNxt Solutions Inc.: BioNxt Advances Cladribine Clinical Program with Completion of the Investigational Medicinal Product Dossier Ahead of Human Clinical StudiesAugust 20, 2026 | finanznachrichten.deTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.October 5 at 1:00 AM | Porter & Company (Ad)BioNxt Solutions Inc.August 12, 2026 | barrons.comBioNxt Solutions Inc.: BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer ExemptionJune 23, 2026 | finanznachrichten.deBioNxt Solutions announces one-year extension on $4.58M debt; issues 16.9M bonus warrantsJune 11, 2026 | msn.comSee More BioNxt Solutions Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like BioNxt Solutions? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioNxt Solutions and other key companies, straight to your email. Email Address About BioNxt SolutionsBioNxt Solutions (OTCMKTS:BNXTF) is a biotechnology company focused on developing pharmaceutical and drug-delivery technologies. Its work centers on alternative dosage forms designed to improve the administration, absorption, and convenience of medicines, including oral dissolvable and sublingual films, transdermal systems, and other novel delivery platforms. The company’s development activities have included pharmaceutical products and delivery systems targeting areas such as neurological disorders and other medical conditions. BioNxt has also pursued the development and commercialization of proprietary formulations and related technologies through partnerships and operating activities in North America and Europe, including Germany. BioNxt Solutions was formerly known as XPhyto Therapeutics Corp. and adopted its current name as it focused more directly on pharmaceutical development and drug-delivery solutions. The company is headquartered in Vancouver, British Columbia, and its leadership has included Chief Executive Officer Hugh Rogers.View BioNxt Solutions ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 09/28 - 10/02Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam?Time to Nibble on MCD Stock After it Enters Oversold Territory?Liberty Energy’s AI Power Push Has Wall Street DividedMcCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal UpsideMicron’s Earnings Reveal Why the AI Memory Boom May Last LongerAnthropic's IPO Could Put Amazon's and Alphabet's Paper Profits to the Test Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
